Approximately 7,400 new cases of the disease are diagnosed in the UK every year
The rare blood disease is estimated to affect only ten to 20 people per million worldwide
The autoimmune disease has a global prevalence of 100 to 350 cases per every one million people
Approximately 18,740 new cases of CLL have been diagnosed in the US this year
RSV is associated with 15,000 hospital admissions in infants under six months every year in England
Nuvaxovid XBB.1.5 is now approved for emergency use in all 194 WHO member states
The regulator will monitor approved BCMA- or CD19-directed autologous CAR-T cell immunotherapies
Approximately 1,650 people in the US are diagnosed with the rare non-cancerous tumours each year
The enzyme replacement therapy will become the first treatment available on the NHS for the rare genetic disease
Brexit means pharma must review its intellectual property rights across Europe
Continuity and stability are vital when it comes to the EMA's relocation when it leaves London
The committee also gives verdict on three other products
The agreement will help provide lifesaving treatments and care for NHS patients
Several disease-modifying treatments for use in Alzheimer's disease are at varying stages of development and regulatory approval
An estimated 66,000 new cases of ovarian cancer are diagnosed in Europe each year
Xtandi is the first androgen receptor signalling inhibitor approved for this patient population
An estimated 26,500 people in the US will be diagnosed with gastric cancer in 2023
The inflammatory skin disease currently affects an estimated 4.4% of adults in the EU
About 290,000 people in the US will be diagnosed with breast cancer in 2023
Novo Nordisk CEO Lars Fruergaard Jørgensen appointed first vice-president and Servier president Olivier Laureau confirmed as second vice-president
Von Baumbach will serve as president of the EFPIA for the next two years
Torbett initially joined the pharma association in March 2016
She joins the UK pharma body as its chief scientific officer
Chair of the board Michelle Brennan is among those newly elected
No results were found
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...